Login

Financial Snapshot

Revenue
TTM
$10.29M
Gross Margin
TTM
41.28%
Net Income
TTM
-$32.62M
Current Assets
Last 4 Quarters
N/A
Current Liabilities
Last 4 Quarters
N/A
Current Ratio
Last 4 Quarters
N/A
Total Assets
2025 Q4
Total Liabilities
2025 Q4
Book Value
2025 Q4
$156.4M
Cash
Last 4 Quarters
N/A
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $350.54 Million

About Prenetics Global Ltd

Prenetics Global Ltd. is a health sciences company, which engages in providing consumer health products and services. The firm operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The firm's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The firm is also engaged in consumer health products by a new health and wellness brand IM8.

Industry: Laboratory Analytical Instruments

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support